Search

Your search keyword '"Baker, Darren P."' showing total 404 results

Search Constraints

Start Over You searched for: Author "Baker, Darren P." Remove constraint Author: "Baker, Darren P."
404 results on '"Baker, Darren P."'

Search Results

151. (DXT65) Longitudinal Disability Follow-up in Patients with 6-Month Confirmed Disability Improvement or Worsening in the CARE-MS and Extension Studies.

152. Smoothelin-A Is Essential for Functional Intestinal Smooth Muscle Contractility in Mice.

154. p21 Both Attenuates and Drives Senescence and Aging in BubR1 Progeroid Mice

155. Two Possible Nymphaeaat Truckle Hill, North Wraxall, Wiltshire

156. In vivo pharmacology and toxicology evaluation of polyethylene glycol-conjugated interferon beta-1a.

157. The Murine Anti-Human Common y Chain Monoclonal Antibody CP.B8 Blocks the Second Step in the...

158. Catabolic ornithine carbamoyltransferase of <em>Pseudomonas aeruginosa</em>.

159. Chromosome missegregation causes colon cancer by APCloss of heterozygosity

160. MotoMail, Recruits, and Families.

161. The yin and yang of the Cdkn2a locus in senescence and aging

162. Understanding Self-Harm and Suicide Websites

163. Aging-Associated Vascular Phenotype in Mutant Mice With Low Levels of BubR1

164. Variability of CYP2J2 expression in human fetal tissues.

165. Securin Associates with APCCdh1 in Prometaphase but its Destruction is Delayed by Rae1 and Nup98 until the Metaphase/Anaphase Transition

166. Control analysis of lipid biosynthesis in tissue cultures from oil crops shows that flux control is shared between fatty acid synthesis and lipid assembly

167. Control mechanisms operating for lipid biosynthesis differ in oil-palm (Elaeis guineensis Jacq.) and olive (Olea europaea L.) callus cultures

168. Mapping of IFN-β Epitopes Important for Receptor Binding and Biologic Activation: Comparison of Results Achieved Using Antibody-Based Methods and Alanine Substitution Mutagenesis

169. Is the P25L a “Real” VHLmutation?

170. Regionalization within the mammalian telencephalon is mediated by changes in responsiveness to Sonic Hedgehog

171. The importance of heteroduplexes in interpreting the results of PCR-RED diagnostic assays: Application to the analysis of mutations in the steroid 21-hydroxylase gene in a case of congenital adrenal hyperplasia

172. An unexpected product from polymerase chain reaction-mediated site-directed mutagenesis due to misalignment of the mismatched primer

173. Engineered Complementation in Escherichia coliAspartate Transcarbamoylase

174. Use of DNA Polymorphisms to Monitor Engraftment after Allogeneic Bone Marrow Transplantation

175. Erroneous Accountability.

176. Proficiency Without Professionalism Equals Mediocrity.

178. D(-)-Mandelate Dehydrogenase of the Yeast Rhodotorula graminis

181. Electrospun Carbon Nanofibers from Kraft Lignin.

182. Rapid Manufacture of Carbon Fiber from Organosolv Lignins.

183. Pathogenic Effects of IFIT2 and Interferon-β during Fatal Systemic Candida albicansInfection

185. Ligand-Stimulated Downregulation of the Alpha Interferon Receptor: Role of Protein Kinase D2.

187. Trademarks may thwart gray market importers.

188. Discovery of structural diverse reversible BTK inhibitors utilized to develop a novel in vivo CD69 and CD86 PK/PD mouse model.

189. D(-)-mandelate dehydrogenase of the yeast Rhodotorula graminis

191. A family's misfortune.

192. Who Knows?

193. Sonic hedgehog signalling in neurons of adult ventrolateral nucleus tractus solitarius.

194. Monitoring the Transition from the T to the R State in E. coli Aspartate Transcarbamoylase by X-ray Crystallography: Crystal Structures of the E50A Mutant Enzyme in Four Distinct Allosteric States

195. Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS Studies.

196. Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies.

197. Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management.

198. Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosis.

199. Potent PDZ-Domain PICK1 Inhibitors that Modulate Amyloid Beta-Mediated Synaptic Dysfunction.

200. Peginterferon Beta-1a Shows Antitumor Activity as a Single Agent and Enhances Efficacy of Standard of Care Cancer Therapeutics in Human Melanoma, Breast, Renal, and Colon Xenograft Models.

Catalog

Books, media, physical & digital resources